Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass

被引:386
作者
Asimakopoulos, G [1 ]
Smith, PLC [1 ]
Ratnatunga, CP [1 ]
Taylor, KM [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll Sch Med, Cardiothorac Unit, London W12 0NN, England
关键词
D O I
10.1016/S0003-4975(99)00781-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiopulmonary bypass is often followed by pulmonary dysfunction as assessed by measuring the alveolar-arterial oxygenation gradient, intrapulmonary shunt, degree of pulmonary edema, pulmonary compliance, and pulmonary vascular resistance. It is also regarded as a risk factor for development of acute respiratory distress syndrome. On the other hand, cardiopulmonary bypass is associated with a whole body inflammatory response, which involves activation of complement, leukocytes, and endothelial cells with secretion of cytokines, proteases, arachidonic acid metabolites, and oxygen free radicals. Leukocyte adhesion to microvascular endothelium, leukocyte extravasation, and tissue damage are the final steps. Although the inflammatory response to cardiopulmonary bypass often remains at subclinical levels, it can also lead to major organ dysfunction and multiple organ failure. This review article summarizes the recent literature on the molecular and cellular mechanisms involved in the phenomenon of pulmonary dysfunction after cardiopulmonary bypass. It also summarizes reports on the prevalence and mortality of acute respiratory distress syndrome after cardiac surgery. (Ann Thorac Surg 1999;68:1107-15) (C) 1999 by The Society of Thoracic Surgeons.
引用
收藏
页码:1107 / 1115
页数:9
相关论文
共 87 条
  • [1] ADHESION MOLECULES AND INFLAMMATORY INJURY
    ALBELDA, SM
    SMITH, CW
    WARD, PA
    [J]. FASEB JOURNAL, 1994, 8 (08) : 504 - 512
  • [2] ASSOCIATION BETWEEN GASTRIC INTRAMUCOSAL PH AND SPLANCHNIC ENDOTOXIN, ANTIBODY TO ENDOTOXIN, AND TUMOR-NECROSIS-FACTOR-ALPHA CONCENTRATIONS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS
    ANDERSEN, LW
    LANDOW, L
    BAEK, L
    JANSEN, E
    BAKER, S
    [J]. CRITICAL CARE MEDICINE, 1993, 21 (02) : 210 - 217
  • [3] ASHBAUGH DG, 1967, LANCET, V2, P319
  • [4] Prevalence of acute respiratory distress syndrome after cardiac surgery
    Asimakopoulos, G
    Taylor, KM
    Smith, PL
    Ratnatunga, CP
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 117 (03) : 620 - 621
  • [5] Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit
    Barstad, RM
    Ovrum, E
    Ringdal, MA
    Oystese, R
    Hamers, MJAG
    Veiby, OP
    Rolfsen, T
    Stephens, RW
    Sakariassen, KS
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (03) : 517 - 525
  • [6] Surfactant medication for acute respiratory distress syndrome
    Baudouin, SV
    [J]. THORAX, 1997, 52 : S9 - S15
  • [7] Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury
    Beghetti, M
    Silkoff, PE
    Caramori, M
    Holtby, HM
    Slutsky, AS
    Adatia, I
    [J]. ANNALS OF THORACIC SURGERY, 1998, 66 (02) : 532 - 534
  • [8] THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION
    BERNARD, GR
    ARTIGAS, A
    BRIGHAM, KL
    CARLET, J
    FALKE, K
    HUDSON, L
    LAMY, M
    LEGALL, JR
    MORRIS, A
    SPRAGG, R
    COCHIN, B
    LANKEN, PN
    LEEPER, KV
    MARINI, J
    MURRAY, JF
    OPPENHEIMER, L
    PESENTI, A
    REID, L
    RINALDO, J
    VILLAR, J
    VANASBECK, BS
    DHAINAUT, JF
    MANCEBO, J
    MATTHAY, M
    MEYRICK, B
    PAYEN, D
    PERRET, C
    FOWLER, AA
    SCHALLER, MD
    HUDSON, LD
    HYERS, T
    KNAUS, W
    MATTHAY, R
    PINSKY, M
    BONE, RC
    BOSKEN, C
    JOHANSON, WG
    LEWANDOWSKI, K
    REPINE, J
    RODRIGUEZROISIN, R
    ROUSSOS, C
    ANTONELLI, MA
    BELOUCIF, S
    BIHARI, D
    BURCHARDI, H
    LEMAIRE, F
    MONTRAVERS, P
    PETTY, TL
    ROBOTHAM, J
    ZAPOL, W
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) : 818 - 824
  • [9] Bhujle R, 1997, ASAIO J, V43, pM739
  • [10] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874